Biblio | Page 3 | Department of Radiology

Found 141 results

Filters: Author is de Leon, Mony J [Clear All Filters]

2017

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al.. 2017. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.

2016

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al.. 2016. Clearance systems in the brain--implications for Alzheimer diseaser.. Nat Rev Neurol. 12(4):248.

Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al.. 2016. Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.

Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V et al.. 2016. Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.. Sleep. 39(6):1253-60.

Kamer AR, Fortea JO, Videla S, Mayoral A, Janal M, Carmona-Iragui M, Benejam B, Craig RG, Saxena D, Corby P et al.. 2016. Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome.. Alzheimers Dement (Amst). 2:49-57.

Varga AW, Wohlleber ME, Giménez S, Romero S, Alonso JF, Ducca EL, Kam K, Lewis C, Tanzi EB, Tweardy S et al.. 2016. Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.. Sleep. 39(11):2041-2048.

Butler T, Li Y, Tsui W, Friedman D, Maoz A, Wang X, Harvey P, Tanzi E, Morim S, Kang Y et al.. 2016. Transient and chronic seizure-induced inflammation in human focal epilepsy.. Epilepsia. 57(9):e191-4.

2015

Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S et al.. 2015. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.. Brain. 138(Pt 9):2701-15.

Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, Carmona-Iragui M, Sala I, Sánchez-Saudinos M-B, Antón-Aguirre S et al.. 2015. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.. Oncotarget. 6(29):26663-74.

Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al.. 2015. Clearance systems in the brain-implications for Alzheimer disease.. Nat Rev Neurol. 11(8):457-70.

Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. 2015. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.. Alzheimers Dement. 11(1):58-69.

Choi S-M, Kim BC, Chang J, Choi K-H, Nam T-S, Kim J-T, Lee S-H, Park M-S, Yoon W, de Leon MJ. 2015. Comparison of the Brain Volume in Essential Tremor and Parkinson's Disease Tremor Using an Automated Segmentation Method.. Eur Neurol. 73(5-6):303-9.

Li Y, Tsui W, Rusinek H, Butler T, Mosconi L, Pirraglia E, Mozley D, Vallabhajosula S, Harada R, Furumoto S et al.. 2015. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.. J Nucl Med. 56(2):270-3.

Kamer AR, Pirraglia E, Tsui W, Rusinek H, Vallabhajosula S, Mosconi L, Yi L, McHugh P, Craig RG, Svetcov S et al.. 2015. Periodontal disease associates with higher brain amyloid load in normal elderly.. Neurobiol Aging. 36(2):627-33.

Osorio RS, Gumb T, Pirraglia E, Varga AW, Lu S-E, Lim J, Wohlleber ME, Ducca EL, Koushyk V, Glodzik L et al.. 2015. Sleep-disordered breathing advances cognitive decline in the elderly.. Neurology. 84(19):1964-71.

2014

Mosconi L, Murray J, Tsui WH, Li Y, Spector N, Goldowsky A, Williams S, Osorio R, McHugh P, Glodzik L et al.. 2014. Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.. Neurology. 82(9):752-60.

Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N et al.. 2014. The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 10(6):713-723.e2.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM et al.. 2014. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.. Alzheimers Dement. 10(6):844-52.

Murray J, Tsui WH, Li Y, McHugh P, Williams S, Cummings M, Pirraglia E, Solnes L, Osorio R, Glodzik L et al.. 2014. FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease.. Adv J Mol Imaging. 4(2):15-26.

Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, Tsui WH, Li Y, Butler T, Osorio RS et al.. 2014. Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.. BMJ Open. 4(6):e004850.

Matthews DC, Davies M, Murray J, Williams S, Tsui WH, Li Y, Andrews RD, Lukic A, McHugh P, Vallabhajosula S et al.. 2014. Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study.. Adv J Mol Imaging. 4(4):43-57.

2013

Mosconi L, Rinne JO, Tsui WH, Murray J, Li Y, Glodzik L, McHugh P, Williams S, Cummings M, Pirraglia E et al.. 2013. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.. Neurobiol Aging. 34(1):22-34.

Glodzik L, Randall C, Rusinek H, de Leon MJ. 2013. Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.. J Alzheimers Dis. 35(3):427-40.